|
|
Gene Symbol |
PIN1 |
|
Aliases |
DOD, UBL5 |
|
Entrez Gene ID |
|
|
Gene Name |
Peptidylprolyl cis/trans isomerase, NIMA-interacting 1 |
|
Chromosomal Location |
19p13.2 |
|
HGNC ID |
|
|
Summary |
Peptidyl-prolyl cis/trans isomerases (PPIases) catalyze the cis/trans isomerization of peptidyl-prolyl peptide bonds. This gene encodes one of the PPIases, which specifically binds to phosphorylated ser/thr-pro motifs to catalytically regulate the post-phosphorylation conformation of its substrates. The conformational regulation catalyzed by this PPIase has a profound impact on key proteins involved in the regulation of cell growth, genotoxic and other stress responses, the immune response, induction and maintenance of pluripotency, germ cell development, neuronal differentiation, and survival. This enzyme also plays a key role in the pathogenesis of Alzheimer's disease and many cancers. Multiple alternatively spliced transcript variants have been found for this gene.[provided by RefSeq, Jun 2011]
|
|
RefSeq DNA |
|
|
RefSeq mRNA |
|
|
e!Ensembl
|
Gene Ontology (GO)
GO ID |
Ontology |
Function |
Evidence |
Reference |
GO:0000413 |
Biological process |
Protein peptidyl-prolyl isomerization |
TAS |
11533658 |
GO:0001666 |
Biological process |
Response to hypoxia |
IDA |
25576397 |
GO:0001932 |
Biological process |
Regulation of protein phosphorylation |
IDA |
24964035 |
GO:0001934 |
Biological process |
Positive regulation of protein phosphorylation |
IGI |
19638580 |
GO:0007088 |
Biological process |
Regulation of mitotic nuclear division |
TAS |
10391244 |
GO:0010468 |
Biological process |
Regulation of gene expression |
IDA |
24964035 |
GO:0030512 |
Biological process |
Negative regulation of transforming growth factor beta receptor signaling pathway |
IDA |
19122240 |
GO:0031647 |
Biological process |
Regulation of protein stability |
IMP |
25576397 |
GO:0032091 |
Biological process |
Negative regulation of protein binding |
IDA |
11533658 |
GO:0032092 |
Biological process |
Positive regulation of protein binding |
IDA |
24964035 |
GO:0032465 |
Biological process |
Regulation of cytokinesis |
IGI |
19638580 |
GO:0032465 |
Biological process |
Regulation of cytokinesis |
IMP |
19638580 |
GO:0035307 |
Biological process |
Positive regulation of protein dephosphorylation |
TAS |
23362255 |
GO:0042177 |
Biological process |
Negative regulation of protein catabolic process |
IDA |
11533658 |
GO:0043547 |
Biological process |
Positive regulation of GTPase activity |
IMP |
20179103 |
GO:0045944 |
Biological process |
Positive regulation of transcription by RNA polymerase II |
IDA |
11533658 |
GO:0046785 |
Biological process |
Microtubule polymerization |
IDA |
26996940 |
GO:0050821 |
Biological process |
Protein stabilization |
IDA |
11533658 |
GO:0051443 |
Biological process |
Positive regulation of ubiquitin-protein transferase activity |
IDA |
19122240 |
GO:0060393 |
Biological process |
Regulation of pathway-restricted SMAD protein phosphorylation |
IDA |
19122240 |
GO:0070373 |
Biological process |
Negative regulation of ERK1 and ERK2 cascade |
IDA |
20179103 |
GO:0090263 |
Biological process |
Positive regulation of canonical Wnt signaling pathway |
IDA |
11533658 |
GO:1900180 |
Biological process |
Regulation of protein localization to nucleus |
IDA |
11533658 |
GO:1902430 |
Biological process |
Negative regulation of amyloid-beta formation |
IMP |
25576397 |
GO:2000146 |
Biological process |
Negative regulation of cell motility |
IDA |
20179103 |
GO:0005634 |
Cellular component |
Nucleus |
IBA |
21873635 |
GO:0005634 |
Cellular component |
Nucleus |
IDA |
16697218, 20179103, 25576397 |
GO:0005634 |
Cellular component |
Nucleus |
TAS |
16697218 |
GO:0005737 |
Cellular component |
Cytoplasm |
IDA |
16697218, 25576397 |
GO:0005829 |
Cellular component |
Cytosol |
IBA |
21873635 |
GO:0030496 |
Cellular component |
Midbody |
IDA |
19638580 |
GO:0098978 |
Cellular component |
Glutamatergic synapse |
IDA |
28458925 |
GO:0099524 |
Cellular component |
Postsynaptic cytosol |
IDA |
28458925 |
GO:0003755 |
Molecular function |
Peptidyl-prolyl cis-trans isomerase activity |
EXP |
20956805 |
GO:0003755 |
Molecular function |
Peptidyl-prolyl cis-trans isomerase activity |
IBA |
21873635 |
GO:0003755 |
Molecular function |
Peptidyl-prolyl cis-trans isomerase activity |
IDA |
19122240 |
GO:0003755 |
Molecular function |
Peptidyl-prolyl cis-trans isomerase activity |
NAS |
16697218 |
GO:0003755 |
Molecular function |
Peptidyl-prolyl cis-trans isomerase activity |
TAS |
11533658, 24964035 |
GO:0005515 |
Molecular function |
Protein binding |
IPI |
11470801, 16189514, 16476580, 16554819, 17906639, 18628984, 19122240, 19131971, 19151708, 19439498, 20179103, 20179161, 20622153, 21516116, 21741598, 21743479, 21847096, 21900206, 21988832, 22158035, 23911326, 24113655, 24265246, 24267382, 25416956, 26655473 |
GO:0008013 |
Molecular function |
Beta-catenin binding |
IPI |
11533658 |
GO:0016859 |
Molecular function |
Cis-trans isomerase activity |
IMP |
25576397 |
GO:0031434 |
Molecular function |
Mitogen-activated protein kinase kinase binding |
IPI |
20179103 |
GO:0032794 |
Molecular function |
GTPase activating protein binding |
IPI |
20179103 |
GO:0048156 |
Molecular function |
Tau protein binding |
NAS |
28386764 |
GO:0050815 |
Molecular function |
Phosphoserine residue binding |
IDA |
10037602, 11533658 |
GO:0050816 |
Molecular function |
Phosphothreonine residue binding |
IDA |
10037602 |
GO:0050816 |
Molecular function |
Phosphothreonine residue binding |
IPI |
10037602 |
GO:0051219 |
Molecular function |
Phosphoprotein binding |
ISS |
23362255 |
|
Protein Information |
|
Protein Name |
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1, PPIase Pin1, protein (peptidyl-prolyl cis/trans isomerase) NIMA-interacting 1, rotamase Pin1 |
|
Function |
Peptidyl-prolyl cis/trans isomerase (PPIase) that binds to and isomerizes specific phosphorylated Ser/Thr-Pro (pSer/Thr-Pro) motifs. By inducing conformational changes in a subset of phosphorylated proteins, acts as a molecular switch in multiple cellular processes (PubMed:21497122, PubMed:22033920, Ref. 21). Displays a preference for acidic residues located N-terminally to the proline bond to be isomerized. Regulates mitosis presumably by interacting with NIMA and attenuating its mitosis-promoting activity. Down-regulates kinase activity of BTK (PubMed:16644721). Can transactivate multiple oncogenes and induce centrosome amplification, chromosome instability and cell transformation. Required for the efficient dephosphorylation and recycling of RAF1 after mitogen activation (PubMed:15664191). Binds and targets PML and BCL6 for degradation in a phosphorylation-dependent manner (PubMed:17828269). Acts as a regulator of JNK cascade by binding to phosphorylated FBXW7, disrupting FBXW7 dimerization and promoting FBXW7 autoubiquitination and degradation: degradation of FBXW7 leads to subsequent stabilization of JUN (PubMed:22608923). May facilitate the ubiquitination and proteasomal degradation of RBBP8/CtIP through CUL3/KLHL15 E3 ubiquitin-protein ligase complex, hence favors DNA double-strand repair through error-prone non-homologous end joining (NHEJ) over error-free, RBBP8-mediated homologous recombination (HR) (PubMed:23623683, PubMed:27561354). |
|
|
|
|
|
UniProt |
|
|
PDB |
2N1O, 1F8A, 1I6C, 1I8G, 1I8H, 1NMV, 1NMW, 1PIN, 1ZCN, 2F21, 2ITK, 2KBU, 2KCF, 2LB3, 2M8I, 2M8J, 2M9E, 2M9F, 2M9I, 2M9J, 2Q5A, 2RUC, 2RUD, 2RUQ, 2RUR, 2XP3, 2XP4, 2XP5, 2XP6, 2XP7, 2XP8, 2XP9, 2XPA, 2XPB, 2ZQS, 2ZQT, 2ZQU, 2ZQV, 2ZR4, 2ZR5, 2ZR6, 3I6C, 3IK8, 3IKD, 3IKG, 3JYJ, 3KAB, 3KAC, 3KAD, 3KAF, 3KAG, |
|
|
|
Interactions |
| |
STRING |
MINT |
IntAct |
ENSP00000216484 |
O15270 |
O15270 |
|
| |
View interactions
|
|
| |
Associated Diseases
Disease group | Disease Name | References |
Endocrine System Diseases |
PCOS |
|
Neoplasms |
Breast Cancer |
|
|
References |
|
|
Galazis Nicolas, Pang Yik-Lam, Galazi Myria, Haoula Zeina, Layfield Robert, Atiomo William |
Nottingham Medical School, University of Nottingham, Queen's Medical Centre Campus Nottingham University Hospital, Nottingham, UK. ngalazis@gmail.com |
Gynecol Endocrinol. 2013 Jul;29(7):638-44. doi: 10.3109/09513590.2013.777416. |
Abstract
There is a need for research studies into the molecular mechanisms underpinning the link between polycystic ovary syndrome (PCOS) and endometrial cancer (EC) to facilitate screening and to encourage the development of novel strategies to prevent disease progression. The objective of this review was to identify proteomic biomarkers of EC risk in women with PCOS. All eligible published studies on proteomic biomarkers for EC identified through the literature were evaluated. Proteomic biomarkers for EC were then integrated with an updated previously published database of all proteomic biomarkers identified so far in PCOS women. Nine protein biomarkers were similarly either under or over expressed in women with EC and PCOS in various tissues. These include transgelin, pyruvate kinase M1/M2, gelsolin-like capping protein (macrophage capping protein), glutathione S-transferase P, leucine aminopeptidase (cytosol aminopeptidase), peptidyl-prolyl cis-transisomerase, cyclophilin A, complement component C4A and manganese-superoxide dismutase. If validated, these biomarkers may provide a useful framework on which the knowledge base in this area could be developed and will facilitate future mathematical modelling to enhance screening and prevention of EC in women with PCOS who have been shown to be at increased risk. |
|
|
|
|
| © 2019, Biomedical Informatics Centre, NIRRH |
National Institute for Research in Reproductive Health, Jehangir Merwanji Street, Parel, Mumbai-400 012
Tel: 91-22-24192104, Fax No: 91-22-24139412
|